Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The use of plant-derived exosome-like nanoparticles as a delivery system of CRISPR/Cas9-based therapeutics for editing long non-coding RNAs in cancer colon cells

14 Jun 2023

Abstract excerpt

Colon cancer is one of the leading causes of cancer in the United States. Colon cancer develops from the many gene mutations found in the genomes of colon cancer cells. Long non-coding RNAs (lncRNAs) can cause the development and progression of many cancers, including colon cancer. LncRNAs have been and could be corrected through the gene-editing technology of the clustered repeats of the clustered regularly...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Cytomegalovirus and herpesvirus research
Share to RNA regulation and disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37388221
DOI: 10.3389/fonc.2023.1194350

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The use of plant-derived exosome-like nanoparticles as a delivery system of CRISPR/Cas9-based therapeutics for editing long non-coding RNAs in cancer colon cellsPMID 37388221Read ↗

Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancerSemantic proximity Read ↗

CRISPR/Cas9: a powerful tool in colorectal cancer researchSemantic proximity Read ↗

Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction.Semantic proximity Read ↗

CRISPR/Cas9-mediated noncoding RNA editing in human cancersSemantic proximity Read ↗

Principles of CRISPR-Cas9 technology: Advancements in genome editing and emerging trends in drug deliverySemantic proximity Read ↗

Innovative Bacterial Therapies and Genetic Engineering Approaches in Colorectal Cancer: A Review of Emerging Strategies and Clinical ImplicationsSemantic proximity Read ↗

Harnessing Gene Editing Technology for Tumor Microenvironment Modulation: An Emerging Anticancer StrategySemantic proximity Read ↗

A Novel Anti-Cancer Therapy: CRISPR/Cas9 Gene EditingSemantic proximity Read ↗

Application of CRISPR/Cas9 gene editing technique in the study of cancer treatmentSemantic proximity Read ↗

The Potential Therapeutic Applications of CRISPR/Cas9 in the Treatment of Gastrointestinal Cancers.Semantic proximity Read ↗

A review: Possible optimization of Cas9-sgRNA nuclease delivery via ingested lipid nanoparticles bioencapsulated within plant cell-based enfoldingSemantic proximity Read ↗

Advances in Nanoparticles as Non-Viral Vectors for Efficient Delivery of CRISPR/Cas9Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.